Based on its recent analysis of the microarrays in molecular diagnostics (MDx) market, Frost & Sullivan recognizes Akonni Biosystems with the 2017 North American New Product Innovation Award.

Akonni’s integrated MDx system, TruDiagnosis^®, is revolutionizing the point-of-care molecular testing market by enabling target detection from a variety of sample types. TruDiagnosis^® is powered by TruArray^®, a patented 3D gel-drop microarray technology for sample screening that instantly indicates the presence of disease markers in real time.

Download: